针对COVID-19的热稳定mRNA疫苗
Na-Na Zhang1, Xiao-Feng Li2, Yong-Qiang Deng2
1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing 100071, China; School of Medicine, Tsinghua University, Beijing 100084, China.
Cell
|August 16, 2020
概括
一种新型的脂质纳米粒子封装信使RNA (mRNA) 疫苗ARCoV针对SARS-CoV-2受体结合域,在临床前模型中显示出强大的中和抗体和完整的保护. 这种COVID-19候选疫苗具有室温稳定性.
科学领域:
- 疫苗学
- 分子生物学
- 免疫学
背景情况:
- 由于COVID-19的流行,需要快速研发疫苗.
- 传递 RNA (mRNA) 疫苗为新出现的传染病提供了多功能平台.
- 脂质纳米粒子 (LNP) 封装增强了mRNA疫苗的输送和稳定性.
研究的目的:
- 开发和评估一种用于预防COVID-19的新型mRNA疫苗候选人ARCoV.
- 在临床前模型中评估ARCoV的免疫性和保护功效.
- 确定ARCoV疫苗的储存稳定性和配方特性.
主要方法:
- 开发一种脂纳米粒子封装的mRNA疫苗,编码SARS-CoV-2受体结合域 (RBD).
- 用ARCoV mRNA-LNP疫苗对小鼠和非人类灵长类动物进行肌肉免疫.
- 对中和抗体标位和Th1偏差细胞反应的评估.
- 挑战使用适应小鼠SARS-CoV-2菌株的研究来评估疫苗的有效性.
- 在液体配方中评估ARCoV在室温中的稳定性.
主要成果:
- 在ARCoV mRNA-LNP免疫接种过程中产生了针对SARS-CoV-2的强有力的中和抗体.
- 在免疫小鼠和非人类灵长类动物中观察到Th1偏差的细胞免疫反应.
- 两剂ARCoV在小鼠中提供了对SARS-CoV-2挑战的完整保护.
- 抗冠状病毒疫苗是液体的,在室温下保持稳定至少一周.
结论:
- 这种ARCoV mRNA疫苗候选产生的免疫力强烈,可以对抗SARS-CoV-2.
- 在临床前模型中,ARCoV显示出完全的保护性,突出显示了其作为COVID-19疫苗的潜力.
- 由于ARCoV的室温稳定性,为疫苗分发提供了后勤优势.
- 目前,ARCoV 正在进入第一阶段临床试验,以进一步评估其对人类的安全性和有效性.
相关概念视频
Microorganisms in Medicine and Therapeutics
758
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
758
Leaky Scanning
5.5K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K
Vaccinations
50.6K
Overview
50.6K


